A proposal to allocate $250,000 to research the safety and efficacy of low-THC cannabis extracts (including tinctures, oils and pills) has been approved with a unanimous 6 to 0 vote by the Nebraska Judiciary Committee.
Legislative Bill 390, introduced by Senator Sue Crawford, would direct the University of Nebraska Medical Center to study the use of cannabis oil that has at least 10% cannabidiol (CBD), and less than 0.3% tetrahydrocannabinol (THC), for the treatment of resistant seizures.
The study would involve participation from around 50 minors, and funding would come from the Nebraska Research Initiative.
“We made sure that it was broad enough and flexible enough for them to be able to do the study [effectively],” says Senator Crawford.
A much broader bill that would legalize the possession and use of medical cannabis – Legislative Bill 643 – is currently awaiting a vote in the Judiciary Committee.